Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer
- PMID: 20813314
- DOI: 10.1053/j.semtcvs.2010.04.003
Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer
Abstract
Lobar resection is currently the standard approach for the treatment of stage I non-small cell lung cancer. Sublobar resection is generally considered a compromise, reserved for high-risk patients because of greater rates of local recurrence compared with lobar resection. Adjuvant radiation therapy may decrease these increased local recurrence rates, but because of respiratory motion and difficulties in identifying the staple line, radiation delivery can be challenging with an external beam approach. Adjuvant intraoperative brachytherapy with the use of low-dose rate iodine-125 seeds placed alongside the surgical staple has been used with success in several centers. A randomized multicenter North American study has also recently completed accrual, but the results of this are not yet available. In the following review, we outline the techniques used, safety considerations, and currently available outcomes of sublobar resection with adjuvant brachytherapy for non-small cell lung cancer.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Sublobar versus lobar resection: current status.Cancer J. 2011 Jan-Feb;17(1):23-7. doi: 10.1097/PPO.0b013e31820a51b6. Cancer J. 2011. PMID: 21263263 Review.
-
Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.Brachytherapy. 2005;4(4):278-85. doi: 10.1016/j.brachy.2005.03.007. Brachytherapy. 2005. PMID: 16344258
-
Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung.Brachytherapy. 2008 Jan-Mar;7(1):50-4. doi: 10.1016/j.brachy.2007.11.003. Brachytherapy. 2008. PMID: 18299113
-
Role of adjuvant radiation (external beam/brachytherapy) for stage I NSCLC.Thorac Surg Clin. 2007 May;17(2):273-8. doi: 10.1016/j.thorsurg.2007.03.013. Thorac Surg Clin. 2007. PMID: 17626405 Review.
-
Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy.Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):105-9. doi: 10.1016/j.ijrobp.2009.10.030. Epub 2010 Apr 10. Int J Radiat Oncol Biol Phys. 2011. PMID: 20382483
Cited by
-
125I Seed Brachytherapy Combined with Single-Agent Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer in the Elderly: A Valuable Solution.Onco Targets Ther. 2020 Oct 16;13:10581-10591. doi: 10.2147/OTT.S272898. eCollection 2020. Onco Targets Ther. 2020. PMID: 33116636 Free PMC article.
-
Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer.Cancer Manag Res. 2020 Sep 9;12:8209-8220. doi: 10.2147/CMAR.S267694. eCollection 2020. Cancer Manag Res. 2020. PMID: 32982417 Free PMC article.
-
Biofunctional core-shell polypyrrole-polyethylenimine nanocomplex for a locally sustained photothermal with reactive oxygen species enhanced therapeutic effect against lung cancer.Int J Nanomedicine. 2019 Feb 28;14:1575-1585. doi: 10.2147/IJN.S163299. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30880966 Free PMC article.
-
Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy.Med Oncol. 2015 Jan;32(1):395. doi: 10.1007/s12032-014-0395-8. Epub 2014 Nov 27. Med Oncol. 2015. PMID: 25428394 Clinical Trial.
-
Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.J Control Release. 2012 Apr 10;159(1):14-26. doi: 10.1016/j.jconrel.2011.11.031. Epub 2011 Dec 1. J Control Release. 2012. PMID: 22154931 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
